Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
Ketamine Reduces Suicidal Ideation in Treatment-Resistant Patients
10/31/2022
Ketamine was found to be an effective treatment for patients with treatment-resistant depression.
Ketamine was found to be an effective treatment for patients with treatment-resistant depression.
Ketamine was found to be an...
10/31/2022
Psych Congress Network

Advertisement

News
Depression Treatment Changes Brain Structure in 6 Weeks
10/31/2022
Adults with MDD showed increased brain connectivity after about 6 weeks of inpatient depression treatment.
Adults with MDD showed increased brain connectivity after about 6 weeks of inpatient depression treatment.
Adults with MDD showed increased...
10/31/2022
Psych Congress Network
News
Patient-Centered, Whole Health Treatment Reduces Suicide Risk in Veterans
10/28/2022
The Veterans Health Administration program lowered risk of suicide in veterans with psychiatric disorders.
The Veterans Health Administration program lowered risk of suicide in veterans with psychiatric disorders.
The Veterans Health...
10/28/2022
Psych Congress Network
News
Depression Risk Rises With More Hours Worked, Study of US First-Year Physicians Finds
10/28/2022
The more hours a first-year medical resident worked in a week, the higher their chances of developing depressive symptoms rose, according to study results published in the New England Journal of Medicine.
The more hours a first-year medical resident worked in a week, the higher their chances of developing depressive symptoms rose, according to study results published in the New England Journal of Medicine.
The more hours a first-year...
10/28/2022
Psych Congress Network

Advertisement

News
Nearly Half of Americans Support Legalization of Psychedelics for Mental Health Treatment
10/28/2022
More than a third of Americans who have seen a therapist within the past 30 days said they feel positively about psychedelics being used as part of mental health treatment, and nearly half would support legalization of at least some...
More than a third of Americans who have seen a therapist within the past 30 days said they feel positively about psychedelics being used as part of mental health treatment, and nearly half would support legalization of at least some...
More than a third of Americans...
10/28/2022
Psych Congress Network
News
Donanemab Improves Exploratory Plasma Biomarkers in Early Alzheimer Disease
10/28/2022
Donanemab treatment lowered plasma biomarkers phosphorylated tau217 and glial fibrillary acidic protein compared with placebo in patients with early symptomatic Alzheimer disease, according to a study published in JAMA Neurology.
Donanemab treatment lowered plasma biomarkers phosphorylated tau217 and glial fibrillary acidic protein compared with placebo in patients with early symptomatic Alzheimer disease, according to a study published in JAMA Neurology.
Donanemab treatment lowered...
10/28/2022
Psych Congress Network
News
First and Only Oral NDMA Receptor Antagonist for MDD Can Now Be Prescribed
10/27/2022
Extended-release dextromethorphan HBr-bupropion HCl (Auvelity™) approved for the treatment of MDD.
Extended-release dextromethorphan HBr-bupropion HCl (Auvelity™) approved for the treatment of MDD.
Extended-release...
10/27/2022
Psych Congress Network

Advertisement

News
US Physicians’ Occupational Stress and Dissatisfaction Greatly Increased in 2021, Survey Says
10/26/2022
Feelings of burnout significantly increased while feelings of job satisfaction markedly decreased in US physicians across nearly all specialties at the end of 2021, roughly 2 years into the COVID-19 pandemic, survey results showed.
Feelings of burnout significantly increased while feelings of job satisfaction markedly decreased in US physicians across nearly all specialties at the end of 2021, roughly 2 years into the COVID-19 pandemic, survey results showed.
Feelings of burnout...
10/26/2022
Psych Congress Network
News
RNA Splicing Defects Contribute to Neurodegeneration in Alzheimer Disease, Model Suggests
10/26/2022
RNA splicing machinery dysfunction may cause neuronal excitatory toxicity and, thus, cognitive impairment in Alzheimer disease.
RNA splicing machinery dysfunction may cause neuronal excitatory toxicity and, thus, cognitive impairment in Alzheimer disease.
RNA splicing machinery...
10/26/2022
Psych Congress Network
News
Reboxetine Prescribed Alone Reduces Sleep Apnea Severity
10/25/2022
Reboxetine prescribed alone can reduce the severity of obstructive sleep apnea (OSA), according to new findings published in the Journal of Clinical Sleep Medicine.
Reboxetine prescribed alone can reduce the severity of obstructive sleep apnea (OSA), according to new findings published in the Journal of Clinical Sleep Medicine.
Reboxetine prescribed alone can...
10/25/2022
Neurology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use